Kura Oncology (KURA) Misses Q2 EPS by 34c

Kura Oncology (NASDAQ: KURA) reported Q2 EPS of ($0.75), $0.34 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $15.3 million versus the consensus estimate of $39.11 million.

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• Explosions heard on Iran's Kharg island - MEHR
• United States Oil Fund (USO) call put ratio 1 call to 1.2 puts as share price up 2.2%
• Active options: GOOGL META AVGO ORCL PLTR NOK BE CIFR NBIS NFLX